DMC Foundation Awards Health Research Grants

In Press Release

DETROIT – The DMC Foundation has awarded four new medical research grants. These grants are designed to augment or extend currently funded research projects that were originally awarded through vetted competitive processes from recognized research programs.

Four research grants were awarded to Wayne State University School of Medicine:

  • $50,000 to identify drugs to treat atherosclerosis using a cytoskeleton protein as a new drug target;
  • $100,000 over 16 months to repurpose the non-toxic drug riluzole to treat triple-negative breast cancer;
  • $100,000 to study the mechanisms of sleep apnea in spinal cord injury patients; and
  • $100,000 to study the pharmacogenomics of caffeine metabolism in neonates.

This is the second round of medical research grants funded by the DMC Foundation, which typically announces medical research grants after its May and December meetings.

Formerly known as the Health & Wellness Foundation, the DMC Foundation was created in 2010 to receive part of the charitable assets transferred from the Detroit Medical Center following its sale to Vanguard Health Systems. In 2013, the DMC Foundation affiliated with the Community Foundation for Southeast Michigan, seeking grantmaking and investment expertise. For more information about the DMC Foundation, visit